LVW Advisors LLC Buys 237 Shares of Becton, Dickinson and Company (NYSE:BDX)

Posted by on Mar 27th, 2023

LVW Advisors LLC lifted its stake in Becton, Dickinson and Company (NYSE:BDX – Get Rating) by 23.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,254 shares of the medical instruments supplier’s stock after buying an additional 237 shares during the period. LVW Advisors LLC’s holdings in Becton, Dickinson and were worth $319,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in the stock. Price T Rowe Associates Inc. MD boosted its stake in shares of Becton, Dickinson and by 108.7% in the second quarter. Price T Rowe Associates Inc. MD now owns 26,814,411 shares of the medical instruments supplier’s stock valued at $6,610,557,000 after buying an additional 13,965,418 shares during the period. Vanguard Group Inc. boosted its stake in shares of Becton, Dickinson and by 1.2% in the third quarter. Vanguard Group Inc. now owns 25,217,976 shares of the medical instruments supplier’s stock valued at $5,619,322,000 after buying an additional 305,044 shares during the period. State Street Corp lifted its stake in Becton, Dickinson and by 0.9% during the third quarter. State Street Corp now owns 12,640,888 shares of the medical instruments supplier’s stock worth $2,816,769,000 after purchasing an additional 109,733 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its stake in Becton, Dickinson and by 16.1% during the second quarter. Massachusetts Financial Services Co. MA now owns 5,219,559 shares of the medical instruments supplier’s stock worth $1,286,779,000 after purchasing an additional 725,606 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in Becton, Dickinson and by 5.0% during the third quarter. Bank of New York Mellon Corp now owns 3,239,476 shares of the medical instruments supplier’s stock worth $721,851,000 after purchasing an additional 152,826 shares during the last quarter. 87.08% of the stock is currently owned by institutional investors.

Becton, Dickinson and Stock Performance

Shares of Becton, Dickinson and stock opened at $240.50 on Monday. The company has a current ratio of 1.07, a quick ratio of 0.60 and a debt-to-equity ratio of 0.56. The business has a 50-day moving average price of $242.95 and a two-hundred day moving average price of $241.03. Becton, Dickinson and Company has a 1-year low of $215.90 and a 1-year high of $277.29. The company has a market cap of $68.28 billion, a P/E ratio of 45.38, a PEG ratio of 2.50 and a beta of 0.53.

Becton, Dickinson and (NYSE:BDX – Get Rating) last issued its quarterly earnings results on Thursday, February 2nd. The medical instruments supplier reported $2.98 earnings per share for the quarter, topping analysts’ consensus estimates of $2.68 by $0.30. The firm had revenue of $4.59 billion during the quarter, compared to the consensus estimate of $4.59 billion. Becton, Dickinson and had a return on equity of 13.52% and a net margin of 8.47%. The business’s revenue was down 2.8% compared to the same quarter last year. During the same period last year, the business posted $3.64 EPS. As a group, analysts anticipate that Becton, Dickinson and Company will post 12.19 EPS for the current year.

Becton, Dickinson and Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 31st. Stockholders of record on Friday, March 10th will be given a dividend of $0.91 per share. The ex-dividend date is Thursday, March 9th. This represents a $3.64 dividend on an annualized basis and a dividend yield of 1.51%. Becton, Dickinson and’s dividend payout ratio (DPR) is presently 68.68%.

Insider Activity at Becton, Dickinson and

In related news, EVP Richard Byrd sold 1,421 shares of the firm’s stock in a transaction dated Friday, February 3rd. The shares were sold at an average price of $248.60, for a total value of $353,260.60. Following the transaction, the executive vice president now owns 4,119 shares of the company’s stock, valued at approximately $1,023,983.40. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.31% of the stock is owned by insiders.

Analyst Ratings Changes

BDX has been the subject of several recent analyst reports. Piper Sandler upped their target price on Becton, Dickinson and from $245.00 to $260.00 and gave the stock a “neutral” rating in a research note on Thursday, February 2nd. StockNews.com began coverage on Becton, Dickinson and in a research note on Thursday, March 16th. They issued a “buy” rating for the company. Citigroup upgraded Becton, Dickinson and from a “sell” rating to a “neutral” rating and increased their price target for the company from $221.00 to $250.00 in a research note on Monday, December 12th. Bank of America upgraded Becton, Dickinson and from a “neutral” rating to a “buy” rating and increased their price target for the company from $250.00 to $290.00 in a research note on Tuesday, January 3rd. Finally, Morgan Stanley increased their price target on Becton, Dickinson and from $290.00 to $295.00 and gave the company an “overweight” rating in a research note on Friday, February 3rd. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $271.89.

Becton, Dickinson and Profile

(Get Rating)

Becton, Dickinson & Co engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery.

Featured Articles

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.